| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 173 |
| 1 | ASPIRIN 325 MG | 169 |
| 2 | ASPIRIN 81 MG | 169 |
| 3 | CLOPIDOGREL | 131 |
| 4 | RIVAROXABAN | 130 |
| 5 | CLOPIDOGREL BISULFATE | 119 |
| 6 | PANTOPRAZOLE | 78 |
| 7 | PREDNISOLONE | 76 |
| 8 | PREDNISOLONE ORAL | 76 |
| 9 | PREDNISOLONE ORAL SOLUTION | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHANOLAMINE OLEATE | 1 | 0.0556 |
| 1 | COAGULATION FACTOR VIIA RECOMBINANT HUMAN | 1 | 0.0108 |
| 2 | CARBON DIOXIDE | 1 | 0.0087 |
| 3 | MENADIONE | 1 | 0.0072 |
| 4 | COAGULATION FACTOR VIIA (RECOMBINANT) | 15 | 0.0055 |
| 5 | CLEVIDIPINE | 2 | 0.0054 |
| 6 | USTEKINUMAB-TTWE | 1 | 0.0052 |
| 7 | CANGRELOR | 2 | 0.0050 |
| 8 | EDOXABAN TOSYLATE | 31 | 0.0045 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 220 |
| 1 | Corticosteroid [EPC] | 187 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 175 |
| 3 | Factor Xa Inhibitor [EPC] | 154 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 112 |
| 5 | Loop Diuretic [EPC] | 108 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 78 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 75 |
| 8 | Osmotic Laxative [EPC] | 66 |
| 9 | Vitamin C [EPC] | 66 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 34 | 0.0015 |
| 2 | Antifibrinolytic Agent [EPC] | 11 | 0.0011 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 112 | 0.0009 |
| 4 | Anti-coagulant [EPC] | 3 | 0.0008 |
| 5 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 6 | Factor Xa Inhibitor [EPC] | 154 | 0.0006 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 9 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |